The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Legend Biotech Corp ADR shares valued at $226,233 were purchased by Huang Ying on May 01 ’25. At $34.55 per share, Huang Ying acquired 6,548 shares.
Also, Yeung Jessie purchased 339 shares, netting a total of over 11,959 in proceeds.
Before that, Huang Ying had added 4,064 shares to its account. In a trade valued at $143,371, the Officer bought Legend Biotech Corp ADR shares for $35.28 each.
As published in their initiating research note from Redburn Atlantic on October 08, 2024, Legend Biotech Corp ADR [LEGN] has been a Buy and the price target has been revised to $86. Analysts at Truist started covering the stock with ‘”a Buy”‘ outlook in a report released in mid June. As of May 24, 2024, H.C. Wainwright has reiterated its “Buy” rating for LEGN. Earlier on May 23, 2024, Deutsche Bank initiated its rating. Their recommendation was “a Buy” for LEGN stock.
Analyzing LEGN Stock Performance
During the last five days, there has been a drop of approximately -9.96%. Over the course of the year, Legend Biotech Corp ADR shares have dropped approximately -3.29%. Shares of the company reached a 52-week high of $40.00 on 02/21/25 and a 52-week low of $29.27 on 04/09/25. A 50-day SMA is recorded $34.36, while a 200-day SMA reached $41.79.
Support And Resistance Levels for Legend Biotech Corp ADR (LEGN)
According to the 24-hour chart, there is a support level at 30.59, which, if violated, would cause prices to drop to 29.72. In the upper region, resistance lies at 32.25. The next price resistance is at 33.04. RSI (Relative Strength Index) is 39.23 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.48, which suggests the price will decrease in the coming days. Percent R is at 81.73%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
